Targeting the tumor-protective effects of squamous cell carcinoma antigen (SCCA1) with emerging tools is helping doctors personalize care for patients with cervical cancer. High levels of SCCA1 are a predictor of poor prognosis in this patient population.

Many patients with multiple myeloma and other blood cancers initially respond well to treatment, but, inevitably, most patients face relapse. Dr.

WHAT YOU'LL HEAR IN THIS EPISODE: 

•    Ways to advocate for yourself while in treatment
•    Candid accounts of side-effects during and after treatment
•    Advice on navigating health care systems

Targeting ACC with treatments that shut off NOTCH1 – a cancer-causing gene – is showing promise for patients with ACC, a rare and aggressive head and neck cancer. Risk factors for ACC remain unknown.

Patients with relapsed acute myeloid leukemia (AML) – a type of blood cancer – face barriers in reaching ideal outcomes and have few avenues for care. Most AML drugs are especially toxic on the body, and it can be challenging to find treatments that are easier to endure.

WHAT YOU'LL HEAR IN THIS EPISODE: 

•    Ways to navigate feelings of survivor’s guilt 
•    Advice on adoption as a cancer survivor 
•    Tips for supporting patients and families through grief 

WHAT YOU'LL HEAR IN THIS EPISODE:

•    Thoughts on how to process cancer statistics mentally and emotionally   
•    How music can be transformative for patients
•    Tips for packing for a hospital stay

Patients with head and neck cancers – the sixth most common cancer worldwide – need heightened and nuanced research for a better chance at life.